TY  - RPRT
TI  - Alternative Structural Lipids Impact mRNA-Lipid Nanoparticle Morphology, Stability, and Activity
AU  - Thorn, Chelsea R. [BioTherapeutics Pharmaceutical Sciences; Pharmaceutical Research and Development, Pfizer Inc.]
AU  - Hickey, James Collin [BioMedicine Design, Pfizer Inc.]
AU  - Chi, Ying-Chih [BioTherapeutics Pharmaceutical Sciences, Analytical Research and Development, Pfizer Inc.]
AU  - Wang, Mingzhang Maple [BioTherapeutics Pharmaceutical Sciences, Analytical Research and Development, Pfizer Inc.]
AU  - Ng Huang, Karina [Vaccines Research and Development, Pfizer Inc.]
AU  - Hong, Sue-Jean [Vaccines Research and Development, Pfizer Inc.]
AU  - Zou, Qin [BioTherapeutics Pharmaceutical Sciences, Analytical Research and Development, Pfizer Inc.]
AU  - Nguyen, Hong-My [Drug Safety Research & Development, Pfizer Inc]
AU  - Pak, Roger H. [BioTherapeutics Pharmaceutical Sciences; Pharmaceutical Research and Development, Pfizer Inc.]
AU  - Lim Soo, Patrick [BioTherapeutics Pharmaceutical Sciences; Pharmaceutical Research and Development, Pfizer Inc.] (ORCID:0009000134779222)
PY  - 2025
DO  - 10.1021/acs.molpharmaceut.5c00824
UR  - https://www.osti.gov/biblio/3576303
ID  - 3576303
ER  -